Kim Lewis University Distinguished Professor of Biology, Director of Antimicrobial Discovery Center k.lewis@neu.edu 617.373.8238 Expertise antimicrobial drug tolerance, drug discovery, microbial biotechnology Kim Lewis in the Press Long Dismissed, Chronic Lyme Disease Is Finally Getting Its Moment Kim Lewis, a biology professor at Northeastern University who researches Lyme disease, thinks that’s because the medical system isn’t comfortable with uncertainty. Giant sloths and woolly mammoths: Mining past creatures’ DNA for future antibiotics “Essentially, it’s a time machine,” said Kim Lewis, who develops new antibiotics at Northeastern University and is not involved in the work. NBC News Genetic study of Lyme disease bacteria offers clues to long-lasting symptoms The new research is at a very early stage, but it is an important step to understanding and treating the disease, said Kim Lewis, a Lyme expert and a professor of biology at Northeastern University in Boston. New bacterial ‘dark matter’ offers hope for a drug-resistant world NovoBiotic Pharmaceuticals, founded by professors Kim Lewis and Slava Epstein from Northeastern University in Boston, has been tapping into that pool by collecting micro-organisms from soil samples, mimicking their natural environment in specially designed chambers, and so cultivating “domesticated” variants capable of growing in the lab. Medical News Today A new treatment for Lyme disease? “Nobody really cared about that compound ever since because it’s very weak against regular bacteria,” says Prof. Kim Lewis, of Northeastern University College of Science, Boston, MA, and co-lead author of the present study. “What we discovered is that, yeah, it is very weak against regular pathogens, but exceptionally potent against spirochetes.” Drug Target Review New antibiotic a possible alternative to treat Lyme disease Researchers at the Northeastern University in Boston and the University of Oklahoma, both US, have identified an antibiotic that may not only work to cure Lyme disease but may also help eradicate its occurrence from the environment. Frontline Explained: How researchers are trying to eradicate Lyme disease Lyme disease may eventually be a thing of the past, says Kim Lewis, professor of biology and director of the Antimicrobial Discovery Center at Northeastern University in the U.S. city of Boston. Deutsche Welle Tackling Lyme disease: How researchers plan to disarm ticks Lyme disease may eventually be a thing of the past, says Kim Lewis, professor of biology and director of the Antimicrobial Discovery Center at Northeastern University in the US city of Boston. Nature News An abandoned antibiotic makes a comeback to fight a common illness To identify one that would target Borreliella burgdorferi, which causes Lyme, Kim Lewis at Northeastern University in Boston, Massachusetts, and his colleagues screened hundreds of strains of soil bacteria. New Scientist Drug treatment for Lyme disease could lead to its eradication “Lyme disease is well-positioned to be eradicated,” says Kim Lewis at Northeastern University in Boston. “We are gearing up, the first field trial will be next summer.” Kim Lewis for Northeastern Global News Northeastern researcher Kim Lewis develops new approach — using soil bacteria — to help accelerate discovery of new antibiotics Northeastern researcher Kim Lewis develops new approach — using soil bacteria — to help accelerate discovery of new antibiotics Federally funded project is aimed at solving the growing problems of antibiotic resistance that contributes to millions of deaths annually. Experimental antibiotic treatment for Lyme heads for human safety trials Experimental antibiotic treatment for Lyme heads for human safety trials A novel Lyme antibiotic treatment developed by Kim Lewis is being screened for toxicity in healthy people during a phase 1 trial. New antibiotic that could treat drug-resistant infections and superbugs discovered by Northeastern microbiologist in collaboration with NovoBiotic New antibiotic that could treat drug-resistant infections and superbugs discovered by Northeastern microbiologist in collaboration with NovoBiotic Professor Kim Lewis worked with NovoBiotic to discover a new antibiotic, clovibactin, that could treat a host of drug-resistant infections. Will the new vaccines prevent Lyme disease? And when will they be available? Will the new vaccines prevent Lyme disease? And when will they be available? As cases of lyme disease surge, questions arise around the delivery and efficacy of a new Pfizer lyme vaccine. Could ‘new’ antibiotic treatment prevent chronic Lyme disease? Could ‘new’ antibiotic treatment prevent chronic Lyme disease? A targeted antibiotic for Lyme disease treatment that maintains a healthy gut microbiome may start human trials next year, researchers say. The teeny, tiny ticks that cause the most Lyme disease are out The teeny, tiny ticks that cause the most Lyme disease are out Nymphal deer ticks are less likely to carry the pathogens that cause Lyme disease than adult ticks, but they are harder to spot. A new antibiotic has been hiding in the gut of a tiny worm. It may be our best weapon against drug-resistant bacteria. A new antibiotic has been hiding in the gut of a tiny worm. It may be our best weapon against drug-resistant bacteria. Kim Lewis, University Distinguished Professor, says we are in the midst of a global antibiotic resistance crisis. Six Northeastern professors named to list of ‘highly cited researchers’ around the globe Six Northeastern professors named to list of ‘highly cited researchers’ around the globe Treating cancer and other diseases in novel ways. Discovering a new antibiotic. Understanding why people become successful. These groundbreaking research achievements are among the accomplishments of six faculty members who have been recognized for the high rate at which their papers have been cited by other researchers. Northeastern University researchers search for the key to treating clinical depression Northeastern University researchers search for the key to treating clinical depression A study led by Northeastern researchers shows there is a potential link between the bacteria that live in our gut and clinical depression. This solver of scientific paradoxes has been named a fellow of the American Association for the Advancement of Science This solver of scientific paradoxes has been named a fellow of the American Association for the Advancement of Science Kim Lewis, a University Distinguished Professor of Biology, has been named a Fellow of the American Association for the Advancement of Science for his discovery of bacterial persister cells.
Long Dismissed, Chronic Lyme Disease Is Finally Getting Its Moment Kim Lewis, a biology professor at Northeastern University who researches Lyme disease, thinks that’s because the medical system isn’t comfortable with uncertainty.
Giant sloths and woolly mammoths: Mining past creatures’ DNA for future antibiotics “Essentially, it’s a time machine,” said Kim Lewis, who develops new antibiotics at Northeastern University and is not involved in the work.
NBC News Genetic study of Lyme disease bacteria offers clues to long-lasting symptoms The new research is at a very early stage, but it is an important step to understanding and treating the disease, said Kim Lewis, a Lyme expert and a professor of biology at Northeastern University in Boston.
New bacterial ‘dark matter’ offers hope for a drug-resistant world NovoBiotic Pharmaceuticals, founded by professors Kim Lewis and Slava Epstein from Northeastern University in Boston, has been tapping into that pool by collecting micro-organisms from soil samples, mimicking their natural environment in specially designed chambers, and so cultivating “domesticated” variants capable of growing in the lab.
Medical News Today A new treatment for Lyme disease? “Nobody really cared about that compound ever since because it’s very weak against regular bacteria,” says Prof. Kim Lewis, of Northeastern University College of Science, Boston, MA, and co-lead author of the present study. “What we discovered is that, yeah, it is very weak against regular pathogens, but exceptionally potent against spirochetes.”
Drug Target Review New antibiotic a possible alternative to treat Lyme disease Researchers at the Northeastern University in Boston and the University of Oklahoma, both US, have identified an antibiotic that may not only work to cure Lyme disease but may also help eradicate its occurrence from the environment.
Frontline Explained: How researchers are trying to eradicate Lyme disease Lyme disease may eventually be a thing of the past, says Kim Lewis, professor of biology and director of the Antimicrobial Discovery Center at Northeastern University in the U.S. city of Boston.
Deutsche Welle Tackling Lyme disease: How researchers plan to disarm ticks Lyme disease may eventually be a thing of the past, says Kim Lewis, professor of biology and director of the Antimicrobial Discovery Center at Northeastern University in the US city of Boston.
Nature News An abandoned antibiotic makes a comeback to fight a common illness To identify one that would target Borreliella burgdorferi, which causes Lyme, Kim Lewis at Northeastern University in Boston, Massachusetts, and his colleagues screened hundreds of strains of soil bacteria.
New Scientist Drug treatment for Lyme disease could lead to its eradication “Lyme disease is well-positioned to be eradicated,” says Kim Lewis at Northeastern University in Boston. “We are gearing up, the first field trial will be next summer.”